E. Kaukel

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2003 · 3.1K citations

Medicine, Oncology, Pharmacology +13

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Frank V. Fossella, Jose R. Pereira, Joachim von Pawel et al. · Journal of Clinical Oncology · 2003 · 943 citations

Medicine, Oncology, Pharmacology +15

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

U. Gatzemeier, Aleksandra Szczęsna, E. Kaukel et al. · Journal of Clinical Oncology · 2007 · 880 citations · Full text

Medicine, Oncology, Pharmacology +14

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

U. Gatzemeier, A Płużańska, A. Szczęsna et al. · Journal of Clinical Oncology · 2004 · 300 citations

Medicine, Oncology, Pharmacology +15

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al. · Journal of Clinical Oncology · 2023 · 253 citations

Medicine, Oncology, Pharmacology +13